The New Approach for Risk Regulation in Banks
New Challenges in Accounting and Finance · 2020
DOI: 10.32038/ncaf.2020.03.01 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Challenges in Accounting and Finance, 2020. Verfasst von Daniela Feschiyan und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The purpose of this report is to present the necessity of proceeding to new reforms in bank regulation and to increase the stability and risk sensitivity of the capital base under applying the Standardised Credit Risk Assessment Approach (SCRA) in banks. The dynamics in the bank regulation and supervision of credit risk assessment approaches are explored. In the paper, a thorough theoretical-methodological and historical-logical analysis was made of the evolution of the development and chronology of the global regulatory frameworks for banks - Basel 1, Basel 2 and Basel 3. The contemporary projections and challenges for the banks' management under the new regulatory and institutional changes are presented. The SCRA is a positive asset in bank capital regulation in contemporary banking. The revisions to the regulatory framework – Basel 3 by is a long continuous process influenced by numerous economic, social and political factors. The preparation of the Bulgarian banking system for a new reform of financial regulation is analyzed. The need for adoption of a new risk-based approach for capital assessment and the importance of transparency in bank financial reporting is proved.
Zitieren
APA
Feschiyan, D., & Andasarova, R. (2020). The New Approach for Risk Regulation in Banks. New Challenges in Accounting and Finance. https://doi.org/10.32038/ncaf.2020.03.01
Vancouver
Feschiyan D, Andasarova R. The New Approach for Risk Regulation in Banks. New Challenges in Accounting and Finance. 2020. doi:10.32038/ncaf.2020.03.01
BibTeX
@article{Feschiyan2020,
author = {Feschiyan, Daniela and Andasarova, Radka},
title = {The New Approach for Risk Regulation in Banks},
journal = {New Challenges in Accounting and Finance},
year = {2020},
doi = {10.32038/ncaf.2020.03.01}
}
EUVIMED